Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma

Fig. 2

Overall KRAS and TP53 mutation profile in matched primary tumor and pancreatic juice samples from PDAC patients. Color coding indicates relationships between mutations detected in the primary tumor and what was found in the corresponding pancreatic juice. The seven cases in which the mutation status (positive or negative) was concordant in both sample types and for both genes are marked at the bottom of the display. For concordance evaluation, only mutations with a detected variant allele frequency (VAF) ≥ 3% were considered

Back to article page